Gen9 supplies Arzeda with megabase-scale synthetic DNA via MAP to speed enzyme, chemical and crop-trait development

Gen9 and Arzeda have signed a supply agreement under Gen9’s Multiplex Access Partnership to provide Arzeda with megabase quantities of synthetic DNA so Arzeda can accelerate development of enzymes, specialty chemicals, crop traits, and pharmaceutical building blocks.